<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(7)</volume><submitter>Aparisi A</submitter><pubmed_abstract>Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence is unknown. Methods (2): We conducted a case-control analysis nested in a prospective cohort study. Individuals were recruited from August 2020 to December 2020. Patients were grouped according to the presence or absence of long-COVID headache for three months after COVID-19 resolution. We compared demographic data, clinical variables, cardio-pulmonary laboratory biomarkers, quality of life, and cardio-pulmonary function between groups. Results (3): A cohort of 70 COVID-19 patients was evaluated. Patients with headaches (n = 10; 14.3%) were more frequently female (100% vs. 58.4%; &lt;i></pubmed_abstract><journal>International journal of environmental research and public health</journal><pagination>3961</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8997887</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache.</pubmed_title><pmcid>PMC8997887</pmcid><pubmed_authors>Iglesias-Echeverria C</pubmed_authors><pubmed_authors>Garcia-Azorin D</pubmed_authors><pubmed_authors>Aparisi A</pubmed_authors><pubmed_authors>Garcia-Gomez M</pubmed_authors><pubmed_authors>Marcos-Mangas M</pubmed_authors><pubmed_authors>Fernandez-de-Las-Penas C</pubmed_authors><pubmed_authors>Carrasco-Moraleja M</pubmed_authors><pubmed_authors>Ybarra-Falcon C</pubmed_authors><pubmed_authors>Valle-Penacoba G</pubmed_authors><pubmed_authors>Guerrero AL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cardio-Pulmonary Dysfunction Evaluation in Patients with Persistent Post-COVID-19 Headache.</name><description>Background (1): Headache is a prevalent symptom experienced during ongoing SARS-CoV-2 infection, but also weeks after recovery. Whether cardio-pulmonary dysfunction contributes causally to headache persistence is unknown. Methods (2): We conducted a case-control analysis nested in a prospective cohort study. Individuals were recruited from August 2020 to December 2020. Patients were grouped according to the presence or absence of long-COVID headache for three months after COVID-19 resolution. We compared demographic data, clinical variables, cardio-pulmonary laboratory biomarkers, quality of life, and cardio-pulmonary function between groups. Results (3): A cohort of 70 COVID-19 patients was evaluated. Patients with headaches (n = 10; 14.3%) were more frequently female (100% vs. 58.4%; &lt;i></description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-26T13:05:22.525Z</modification><creation>2025-04-06T14:09:35.663Z</creation></dates><accession>S-EPMC8997887</accession><cross_references><pubmed>35409644</pubmed><doi>10.3390/ijerph19073961</doi></cross_references></HashMap>